Therefore, one may hypothesize that by downregulating CD46 on the surface of astrocytes, HHV-6 infection, and especially HHV-6A, may lead to a dysregulation of complement inhibition in the parenchyma and thus contribute to the inflammatory response seen in MS. This evidence concerns the gene CD46 and myeloid sarcoma.